Edition:
United States

Protalix Biotherapeutics Inc (PLX)

PLX on American Stock Exchange

0.61USD
16 Dec 2017
Change (% chg)

$-0.01 (-0.92%)
Prev Close
$0.62
Open
$0.62
Day's High
$0.62
Day's Low
$0.61
Volume
741,056
Avg. Vol
1,074,128
52-wk High
$1.51
52-wk Low
$0.28

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta 0.19 0.82 0.91
Price to Sales (TTM) 4.54 122.78 5.95
Price to Book (MRQ) -- 23.45 5.68
Price to Tangible Book (MRQ) -- 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions -- 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 61.16 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago 164.88 29.98 5.62
Sales - 5 Yr. Growth Rate 25.39 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -18.16 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago -64.77 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -31.68 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.64 1.79 2.55
Current Ratio (MRQ) 1.92 5.62 3.56
LT Debt to Equity (MRQ) -- 16.22 13.38
Total Debt to Equity (MRQ) -- 18.71 19.38
Interest Coverage (TTM) -11.05 -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 17.11 44.18 54.91
Gross Margin - 5 Yr. Avg. 65.25 55.78 52.46
EBITD Margin (TTM) -168.09 -- --
EBITD - 5 Yr. Avg -234.27 -215.66 15.63
Operating Margin (TTM) -103.91 -642.63 6.56
Operating Margin - 5 Yr. Avg. -228.24 -232.87 11.00
Pre-Tax Margin (TTM) -385.91 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -264.24 -233.04 11.41
Net Profit Margin (TTM) -385.91 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -264.24 -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 285,581 22,314,532 851,801,741
Net Income/Employee (TTM) -1,102,079 -1,997,855 99,542,701
Receivable Turnover (TTM) 4.02 26.15 6.13
Inventory Turnover (TTM) 2.53 2.62 3.56
Asset Turnover (TTM) 0.29 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -110.63 -9.39 11.31
Return on Assets - 5 Yr. Avg. -31.31 0.28 12.28
Return on Investment (TTM) -153.81 -11.76 14.43
Return on Investment - 5 Yr. Avg. -51.52 3.42 16.07
Return on Equity (TTM) -- -36.72 16.01
Return on Equity - 5 Yr. Avg. -- 5.75 17.27
  1 Year 3 Year 5 Year
Sales % 110.79 -- 25.39
EPS (TTM) % -0.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Protalix Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.72 -11.23 26 94
13 Week 8.65 5.25 69 75
26 Week -26.94 -29.30 27 59
52 Week 71.80 64.76 80 58
YTD 35.07 30.64 70 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 10.27%
# of Holders: 43
Total Shares Held: 14,356,887
3 Mo. Net Change: 1,886,228
# New Positions: 5
# Closed Positions: 6
# Increased Positions: 8
# Reduced Positions: 16
# Net Buyers: -8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.